Leveraging artificial intelligence to better diagnose, monitor, and treat disease: Applications in MS

March 25, 2022
DNA sequencing

This article was originally published in MedTech Outlook.

With the emergence of more digital health technologies in recent years, artificial intelligence (AI) has rapidly expanded in healthcare for a range of applications including handling of administrative logistics at hospitals and other medical facilities, assessment of patient health data, and analysis of novel molecules in drug discovery. AI applications are also helping to provide a better understanding of disease progression, leading to improvements in diagnosis, monitoring, and treatment of specific diseases and conditions. Multiple sclerosis (MS) is one disease area where AI is providing benefit to physicians and patients. Given the unknown cause and the lack of reliable biomarkers, MS presents significant challenges in diagnosis and treatment. Several companies are incorporating AI solutions into their drug development and commercialization strategies to address these challenges.

Key contacts

Additional contributors